RenovoRx Inc
NASDAQ:RNXT

Watchlist Manager
RenovoRx Inc Logo
RenovoRx Inc
NASDAQ:RNXT
Watchlist
Price: 0.9 USD 3.45% Market Closed
Market Cap: 33m USD

Net Margin
RenovoRx Inc

-1 196.7%
Current
-2 118%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 196.7%
=
Net Income
-11.1m
/
Revenue
928k

Net Margin Across Competitors

No Stocks Found

RenovoRx Inc
Glance View

Market Cap
33m USD
Industry
Biotechnology

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for the local treatment of solid tumors. The company is headquartered in San Jose, California and currently employs 6 full-time employees. The company went IPO on 2021-08-17. The firm is focused on developing therapies for the local treatment of solid tumors. The firm's lead product candidate RenovoGem. Its other product candidate include Renovo Trans-Arterial Micro-Perfusion (RenovoTAMP), and RenovoCath delivery system. RenovoGem, is a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath. Its therapy platform, RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) is focused on optimizing drug concentration in solid tumors using small molecule chemotherapeutics that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall to bathe these difficult-to-reach tumors in chemotherapy.

RNXT Intrinsic Value
4.45 USD
Undervaluation 80%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 196.7%
=
Net Income
-11.1m
/
Revenue
928k
What is the Net Margin of RenovoRx Inc?

Based on RenovoRx Inc's most recent financial statements, the company has Net Margin of -1 196.7%.

Back to Top